Undervalued Sabre’s Technology Transformation on Track
We expect robust demand recovery in the next two years.
We expect robust demand recovery in the next two years.
Sabre’s shares rose a midteens percentage, as its long-term technology transformation plan first outlined in February 2020 (which stands to reduce costs, improve reliability, and speed innovation) remains on track, despite severe demand headwinds created by the pandemic the past two years. Having largely accounted for this with operating margins surpassing 20% by 2026 versus 9% reported in 2019, we don’t expect a meaningful change to our $15 fair value estimate, leaving shares undervalued.
Sabre continues to see its 2019-24 technology investments leading to $350 million to $450 million in hosting cost and capital expenditure savings by mid-decade, generating a 10-year ROI of 30%-35%. We maintain our long-held view that this transformation stands to make the company more competitive in an industry set to experience dynamic change in retailing and distribution of travel content, supporting its network, switching cost, and efficient scale advantages (sources of its narrow moat).
Turning to the current landscape, Sabre’s corporate travel exposure (50% of prepandemic demand) continues to lag the leisure trip recovery but is showing signs of improvement. Sabre’s fourth-quarter air bookings reached 45% of 2019 levels, directly in line with our forecast and up from 38% last quarter. For 2021, air bookings reached 37% of 2019 levels, up from 21% in 2020. Like peers, omicron impacted Sabre’s performance in December and January, when air bookings dropped to 39% and 29% of 2019 levels, respectively, versus the 51% and 44% seen in November and October. February air bookings are on track to return to November’s high-water mark. We expect Sabre’s air volumes of to approach 60% of 2019 levels in 2022 and above 70% in 2023, with a full air booking recovery around 2028. Meanwhile, Sabre posted an EBITDA loss of $261 million versus our $316 million loss estimate. We expect EBITDA of around $900 million by 2025, as demand recovers under a more cost-efficient structure.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days. |
Dan Wasiolek does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.